NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Radius 

300 Technology Square
Fifth Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-551-4700 Fax: 617-551-4701


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis 8/5/2009 9:10:49 AM    More...
Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 3/24/2009 9:37:59 AM    More...
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 11/20/2008 7:47:42 AM    More...
Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions 6/9/2008 8:18:54 AM    More...
Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis; Milestone triggers $28.3M Second-tranche Investment 4/2/2008 6:44:43 AM    More...
Karo Bio AB Reacquires Rights to SARM Compounds from Radius 2/28/2008 9:38:07 AM    More...
Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 1/30/2008 7:46:11 AM    More...
Radius Raises $57.5 Million in Second Private Financing Round 4/2/2007 9:43:14 AM    More...
Radius Appoints Nick Harvey Senior Vice President And Chief Financial Officer 1/2/2007 6:23:43 PM    More...
Radius And Karo Bio AB Announce Licensing Agreement For Novel SARM Compounds 9/12/2006 1:57:27 PM    More...
12